Intrinsic Resistance of Burkholderia cepacia Complex to Benzalkonium Chloride
Open Access
- 30 December 2016
- journal article
- research article
- Published by American Society for Microbiology in mBio
- Vol. 7 (6) , e01716-16
Abstract
Pharmaceutical products that are contaminated with Burkholderia cepacia complex (BCC) bacteria may pose serious consequences to vulnerable patients. Benzyldimethylalkylammonium chloride (BZK) cationic surfactants are extensively used in medical applications and have been implicated in the coselection of antimicrobial resistance. The ability of BCC to degrade BZK, tetradecyldimethylbenzylammonium chloride (C 14 BDMA-Cl), dodecyldimethylbenzylammonium chloride (C 12 BDMA-Cl), decyldimethylbenzylammonium chloride (C 10 BDMA-Cl), hexyldimethylbenzylammonium chloride, and benzyltrimethylammonium chloride was determined by incubation in 1/10-diluted tryptic soy broth (TSB) to determine if BCC bacteria have the ability to survive and inactivate these disinfectants. With BZK, C 14 BDMA-Cl, and C 12 BDMA-Cl, inhibition of the growth of 20 BCC strains was observed in disinfectant solutions that ranged from 64 to 256 µg/ml. The efflux pump inhibitor carbonyl cyanide m -chlorophenylhydrazone increased the sensitivity of bacteria to 64 µg/ml BZK. The 20 BCC strains grew well in 1/10-diluted TSB medium with BZK, C 12 BDMA-Cl, and C 10 BDMA-Cl; they absorbed and degraded the compounds in 7 days. Formation of benzyldimethylamine and benzylmethylamine as the initial metabolites suggested that the cleavage of the C alkyl-N bond occurred as the first step of BZK degradation by BCC bacteria. Proteomic data confirmed the observed efflux activity and metabolic inactivation via biodegradation in terms of BZK resistance of BCC bacteria, which suggests that the two main resistance mechanisms are intrinsic and widespread. IMPORTANCE Benzyldimethylalkylammonium chloride is commonly used as an antiseptic in the United States. Several recent microbial outbreaks were linked to antiseptics that were found to contain strains of the Burkholderia cepacia complex. Burkholderia species survived in antiseptics, possibly because of the degradation of antiseptic molecules or regulation of relevant gene expression. In this study, we assessed the efflux pump and the potential of B. cepacia complex bacteria to degrade benzyldimethylalkylammonium chloride and improved our understanding of the resistance mechanisms, by using proteomic and metabolic information. To our knowledge, this is the first systematic report of the intrinsic mechanisms of B. cepacia complex strain resistance to benzyldimethylalkylammonium chloride, based on the metabolic and proteomic evidence for efflux pumps and the complete biodegradation of benzyldimethylalkylammonium chloride.Keywords
This publication has 67 references indexed in Scilit:
- Enzymes and genes involved in aerobic alkane degradationFrontiers in Microbiology, 2013
- Survival of Burkholderia pseudomallei in distilled water for 16 yearsTransactions of the Royal Society of Tropical Medicine and Hygiene, 2011
- Polycyclic Aromatic Hydrocarbon Metabolic Network in Mycobacterium vanbaaleniiPYR-1Journal of Bacteriology, 2011
- In Vitro Susceptibility of Burkholderia vietnamiensis to AminoglycosidesAntimicrobial Agents and Chemotherapy, 2011
- Molecular Mechanisms of Chlorhexidine Tolerance in Burkholderia cenocepacia BiofilmsAntimicrobial Agents and Chemotherapy, 2011
- The Changing Microbial Epidemiology in Cystic FibrosisClinical Microbiology Reviews, 2010
- Biocide susceptibility of the Burkholderia cepacia complexJournal of Antimicrobial Chemotherapy, 2009
- The Genome of Burkholderia cenocepacia J2315, an Epidemic Pathogen of Cystic Fibrosis PatientsJournal of Bacteriology, 2009
- Outbreaks Associated with Contaminated Antiseptics and DisinfectantsAntimicrobial Agents and Chemotherapy, 2007
- Adaptation of Pseudomonas sp. Strain 7-6 to Quaternary Ammonium Compounds and Their Degradation via Dual PathwaysApplied and Environmental Microbiology, 2007